跳至主要内容
临床试验/NL-OMON39378
NL-OMON39378已完成不适用

Systemic therapy with or without Up front surgery of the primary tumor in Breast cancer patients with distant Metastases at Initial presenTation (SUBMIT, BOOG 2010-05) - SUBMIT

Jeroen Bosch Ziekenhuis0 个研究点目标入组 516 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
516

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Newly diagnosed primary distant metastatic breast cancer (M1)
  • Anticipated survival of at least 6 months
  • Histological proven breast cancer, hormonal and HER2Neu status should be known
  • T1-T3, resectable T4 status, N0-N3
  • Performance status of the patient should allow surgery/systemic therapy
  • Age 18 years, or older
  • Informed consent

排除标准

  • Primary invasive breast cancer in medical history
  • Other malignancy within the last 10 years, besides basal cell carcinoma of the skin or early stage cervical cancer
  • Surgical treatment / radiotherapy of this breast tumor before randomization
  • Irresectable T4 breast tumor
  • Synchronous bilateral breast cancer

研究者

发起方
Jeroen Bosch Ziekenhuis

相似试验